Gary Hennerberg
Direttore/Membro del Consiglio presso BIOREGENX, INC.
Patrimonio netto: 525 955 $ in data 31/05/2024
Profilo
Gary Hennerberg is currently working as the Secretary & Director at BioRegenx, Inc. He previously worked at BioRegenx, Inc. as the Chief Marketing Officer & Director.
He completed his undergraduate degree at Fort Hays State University in 1978.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
BIOREGENX INC
1.72% | 08/03/2024 | 16 436 000 ( 1.72% ) | 525 952 $ | 31/05/2024 |
FINDIT INC PFD A
0.00% | 08/03/2024 | 108 ( 0.00% ) | 3 $ | 31/05/2024 |
Posizioni attive di Gary Hennerberg
| Società | Posizione | Inizio |
|---|---|---|
| BIOREGENX, INC. | Direttore/Membro del Consiglio | 08/03/2024 |
Precedenti posizioni note di Gary Hennerberg
| Società | Posizione | Fine |
|---|---|---|
BioRegenx, Inc.
 BioRegenx, Inc. Pharmaceuticals: OtherHealth Technology Part of Findit, Inc., BioRegenx, Inc. is a holding company that consists of Microvascular Health Solutions, LLC, My Body RX, LLC, and NuLife Sciences, Inc. The company is based in Chattanooga, TN. The company and its subsidiaries offer 360-degree solutions, which include leading-edge testing technologies and nutraceutical solutions. The patented Endocalyx Pro™ and additional synergistic dietary supplements sold under the My Body RX brand are part of the nutraceuticals offered. The customer base of BioRegenx subsidiaries includes medical professionals, brand partners, and consumers from throughout North America. The CEO of the company is William Resides. BioRegenx was acquired by Findit, Inc. on March 31, 2023. | Direttore/Membro del Consiglio | - |
Formazione di Gary Hennerberg
| Fort Hays State University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
BioRegenx, Inc.
BioRegenx, Inc. Pharmaceuticals: OtherHealth Technology Part of Findit, Inc., BioRegenx, Inc. is a holding company that consists of Microvascular Health Solutions, LLC, My Body RX, LLC, and NuLife Sciences, Inc. The company is based in Chattanooga, TN. The company and its subsidiaries offer 360-degree solutions, which include leading-edge testing technologies and nutraceutical solutions. The patented Endocalyx Pro™ and additional synergistic dietary supplements sold under the My Body RX brand are part of the nutraceuticals offered. The customer base of BioRegenx subsidiaries includes medical professionals, brand partners, and consumers from throughout North America. The CEO of the company is William Resides. BioRegenx was acquired by Findit, Inc. on March 31, 2023. | Health Technology |
| Findit, Inc. |
- Borsa valori
- Insiders
- Gary Hennerberg
